NeuroSense Therapeutics Ltd. NRSN
1.69 USD -0.07 (-3.98%)
Regular-session close
1.71 +0.02 +1.18%
After hours · Nov 13, 4:00 PM ET
1.60 Day range 1.78
1.10 52-week range 25.40
- YTD
- -89.01%
- 1 year
- -90.80%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -11.09M | -9.90M | -12.05M | -10.55M | -2.98M | |
| -11.13M | -10.21M | -10.11M | -10.49M | -3.22M | |
| -8.80 | -10.80 | -14.80 | -18.20 | -10.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 166.00K | 3.38M | 2.64M | 3.54M | 11.06M | |
| 1.03M | 4.58M | 3.19M | 7.72M | 11.43M | |
| 2.59M | 1.99M | 4.94M | 1.87M | 2.42M | |
| 72.00K | 0 | 73.00K | 147.00K | 0 | |
| -1.56M | 2.58M | -1.76M | 5.84M | 9.01M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -7.67M | -10.13M | -8.35M | -7.62M | -1.54M | |
| -8.00K | 1.00K | 3.47M | -3.59M | -17.00K | |
| 4.43M | 10.91M | 3.98M | 3.77M | 11.90M | |
| -8.00K | -3.00K | -29.00K | -70.00K | -17.00K | |
| -3.21M | 738.00K | -903.00K | -7.52M | 10.36M |
